Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Event Review: European Union Ban on Human Embryonic Stem Cell Patents - A Threat to Science and the Rule of Law

31 January 2012

By Dr Amy Strange

Postdoctoral researcher, Wellcome Trust Centre for Human Genetics, University of Oxford

Appeared in BioNews 642

 

European Union Ban on Human Embryonic Stem Cell Patents: A Threat to Science and the Rule of Law

Organised by the University of Oxford

Oxford Martin School, University of Oxford, Old Indian Institute, 34 Broad Street, Oxford OX1 3BD, UK

Friday 20 January 2012

'European Union Ban on Human Embryonic Stem Cell Patents: A Threat to Science and the Rule of Law', organised by the University of Oxford, Friday 20 January 2012

 


The recent ruling of the European Court of Justice (ECJ) excluding inventions relating to human embryonic stem cells (ES cells) from patentability has sparked a heated debate in the bioscience, ethics and law communities (1).

It was the topic up for discussion at a lunchtime seminar in the Oxford Martin School, University of Oxford, given by Aurora Plomer, professor of law and bioethics at Sheffield University, who described the ruling as having 'serious flaws'.

I was one of a handful of scientists in the audience, which was dominated by lawyers and bioethicists for whom the presentation was more directly aimed. As a result I struggled to appreciate the intricacies of all of Professor Plomer's arguments but she made it immediately clear that this was a landmark case: 'The ruling is extremely important. It is the first time that the Commission's court has inferred legal protection on frozen human embryos, albeit on the back of patent laws'.

With such a contentious subject under scrutiny, I felt compelled to at least try and keep up for the hour-long session.

Professor Plomer began by putting the story into context, starting with the case between Greenpeace and German neuroscientist, Professor Oliver Brüstle. In 1999 Professor Brüstle was granted a patent relating to his work on human ES cells. Greenpeace had challenged the patent in the German courts, which in turn asked the ECJ for its interpretation of 'human embryo' under the 1998 EU Directive on the legal protection of biotechnological inventions (98/44/EC) for it to determine its validity (2). The 1998 Directive states, 'uses of human embryos for industrial or commercial purposes must also be excluded from patentability'.

Professor Plomer admitted that she had been 'looking forward to the ruling', as the 1998 Directive was unclear both in terms of the definition of 'moral' and the scope of the exclusions; did it only apply to embryos or also to cell lines derived from embryos? Greenpeace v Brüstle was to be the case that would answer some of these questions.

She had high hopes that the ruling would be potentially a 'very good intervention'. However, it was not the result Professor Plomer had expected. She was 'dismayed' as the ECJ effectively ruled that the patent ban extended into therapeutic uses of embryos and included any derivative resulting from the destruction of embryos, including ES cells lines.

The ruling surprised Professor Plomer as she believes it achieves the exact opposite of the 1998 Directive on which it is based, which was not supposed to block patents or bring about new laws, but to facilitate competiveness and harmonise existing laws. 'How could the ECJ come to this view? From a legal point it is so problematic', she said.

Interestingly, Professor Plomer points out the contradiction of the ruling, which is 'at odds with the Commission's funding policy on ES cells research'. The EU funds research into ES cells yet bans patent resulting from such work as 'immoral'.

In the many questions following the talk, one attendee asked whether the ruling was a judgment on the morality of the patent system or the morality of the research on human ES cells? Professor Plomer dismissed this distinction, saying that either way it cast a shadow on the morality of the research. She accredited the ECJ with employing religious views, which led it to decide that the patent is immoral because they believe the research is immoral.

A fellow scientist in the audience raised the idea as to whether it was such a bad thing to prevent patents in embryo related work, complaining that patents can lead to stagnation of research. Professor Plomer agreed to some extent, but was worried about the precedent the ECJ had set by going against other directives, and the future implications this could hold.

'It is very important to monitor the developments in the EU now. Clearly the court has plenty of legal material to create further limits', she said. 'We are into uncharted territory, it is bad news really'.

As I left the seminar I was unsure of how the ruling would affect science. In the short term it seems little will change for the lab scientist. The ruling was, after all, about patents not research. It could have a more direct impact for research if funding is cut as a result of the area becoming unprofitable, or if Professor Plomer's fears are recognised and the laws governing scientific research are changed. Scientists will have to watch and wait.


SOURCES & REFERENCES
European Court of Justce | 18 October 2011
 
Europa | 06 July 1998
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

08 October 2012 - by Tom Barrow 
The future funding of human embryonic stem cell research under the European Union may be in jeopardy after its inclusion in the next research funding programme is challenged by MEPs....
25 June 2012 - by Antony Blackburn-Starza 
Six major UK research funding bodies have called for the continued funding of human embryonic stem cell (hESC) research in the EU's programme for research and development...
18 June 2012 - by Dr Martin Turner and Dr Ian Turner 
By exploring the legislative history and case law of patents both in Europe and the US, Oliver Mills asks why morality has become such a pervasive issue and whether European law in its current state is fit for purpose...
15 May 2012 - by Dr Jackie Leach Scully 
We know very little about what 'ordinary' lay members of faith groups - those who are not scientists, philosophers or religious leaders - think about the acceptability of new reproductive and genetic technologies. A team of researchers from Newcastle and Durham Universities is currently carrying out research exploring some of these issues and would like your help...
06 February 2012 - by Dr Gill Haddow 
DNA databanks - controversial yet exciting endeavours to collect and store individuals' DNA alongside other information - are the subject of Bernice Elger's latest book, which Gill Haddow describes as fundamental reading...

24 October 2011 - by Antony Blackburn-Starza 
The European Court of Justice (ECJ) has ruled that stem cell processes which require the prior destruction of human embryos or are based upon the use of human embryos are not patentable. The decision may have wide implications for scientists engaged in embryonic stem cell research....
28 March 2011 - by Nishat Hyder 
An advisor to the European Court of Justice (ECJ) has issued a preliminary opinion stating that procedures involving human embryonic stem (hES) cell lines are not patentable....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation